Literature DB >> 16541464

ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra.

Rolf F Schulte1, Peter Boesiger.   

Abstract

A two-dimensional fitting procedure is introduced, capable of extracting the full amount of information from 2D J-resolved magnetic resonance spectroscopic data. The fitting procedure uses a linear combination of 2D model spectra. For reducing the degrees of freedom and increasing robustness, it is divided into a non-linear outer loop and an inner linear least-squares fit for the concentrations. In vitro and in vivo experiments on a whole-body 3 T MR scanner show the detectability of a wide range of metabolites in the human brain, namely total creatine, N-acetylaspartate, N-acetylaspartylglutamate, choline-containing compounds, glutamate, myo-inositol, glutathione, scyllo-inositol, gamma-aminobutyric acid, alanine and ascorbic acid.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541464     DOI: 10.1002/nbm.1026

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  77 in total

1.  Phase-adjusted echo time (PATE)-averaging 1 H MRS: application for improved glutamine quantification at 2.89 T.

Authors:  Andrew P Prescot; Todd Richards; Stephen R Dager; Changho Choi; Perry F Renshaw
Journal:  NMR Biomed       Date:  2012-03-12       Impact factor: 4.044

Review 2.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

3.  Two-dimensional linear-combination model fitting of magnetic resonance spectra to define the macromolecule baseline using FiTAID, a Fitting Tool for Arrays of Interrelated Datasets.

Authors:  Daniel G Q Chong; Roland Kreis; Christine S Bolliger; Chris Boesch; Johannes Slotboom
Journal:  MAGMA       Date:  2011-03-20       Impact factor: 2.310

4.  Low-power adiabatic sequences for in vivo localized two-dimensional chemical shift correlated MR spectroscopy.

Authors:  Ovidiu C Andronesi; Saadallah Ramadan; Carolyn E Mountford; A Gregory Sorensen
Journal:  Magn Reson Med       Date:  2010-10-01       Impact factor: 4.668

Review 5.  Proton MR spectroscopy of the brain at 3 T: an update.

Authors:  Alfonso Di Costanzo; Francesca Trojsi; Michela Tosetti; Timo Schirmer; Silke M Lechner; Teresa Popolizio; Tommaso Scarabino
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 5.315

6.  High resolution NMR spectroscopy of rat brain in vivo through indirect zero-quantum-coherence detection.

Authors:  Robin A de Graaf; Douglas L Rothman; Kevin L Behar
Journal:  J Magn Reson       Date:  2007-06-10       Impact factor: 2.229

7.  Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo.

Authors:  M Albert Thomas; Thomas Lange; S Sendhil Velan; Rajakumar Nagarajan; Steve Raman; Ana Gomez; Daniel Margolis; Stephany Swart; Raymond R Raylman; Rolf F Schulte; Peter Boesiger
Journal:  MAGMA       Date:  2008-07-17       Impact factor: 2.310

8.  N-acetylaspartate normalization in bipolar depression after lamotrigine treatment.

Authors:  Paul E Croarkin; M Albert Thomas; John D Port; Joshua M Baruth; Doo-Sup Choi; Osama A Abulseoud; Mark A Frye
Journal:  Bipolar Disord       Date:  2014-12-12       Impact factor: 6.744

9.  Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment-naive individuals with alcohol use disorder.

Authors:  James J Prisciandaro; Joseph P Schacht; Andrew P Prescot; Helena M Brenner; Perry F Renshaw; Truman R Brown; Raymond F Anton
Journal:  Addict Biol       Date:  2019-08-01       Impact factor: 4.280

10.  Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole.

Authors:  Brian P Brennan; James I Hudson; J Eric Jensen; Julie McCarthy; Jacqueline L Roberts; Andrew P Prescot; Bruce M Cohen; Harrison G Pope; Perry F Renshaw; Dost Ongür
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.